Rheumatoid arthritis is treated with a combination of medications that slow joint damage, therapies that preserve daily function, and lifestyle adjustments that help manage symptoms. Treatment typically begins with a class of drugs called disease-modifying antirheumatic drugs (DMARDs) as soon as the diagnosis is confirmed, because early intervention dramatically improves long-term outcomes. With consistent treatment, roughly 89% of patients can reach remission within five years.
Methotrexate: The Standard Starting Point
Methotrexate is the first medication most people with rheumatoid arthritis will be prescribed. It works by dialing down the overactive immune response that causes joint inflammation and damage. The usual starting dose is taken just once a week, either as a tablet or an injection, and can be gradually increased over time based on how well you respond.
Methotrexate doesn’t work overnight. Most guidelines recommend waiting three to six months to judge whether it’s doing enough before considering a change. During that window, your doctor will likely prescribe a short course of a steroid (typically prednisone) as “bridging therapy” to control inflammation while the methotrexate builds up in your system. Current guidelines recommend tapering off steroids within three months if possible, and most rheumatologists aim to get you below a very low daily dose within that time frame before stopping entirely.
While you’re on methotrexate, you’ll need regular blood work. For the first six months, expect monthly blood tests checking your liver function, kidney function, and blood cell counts. After that, testing typically moves to every two months. This monitoring catches any side effects early, which makes the medication much safer than it might sound.
Biologics: When Methotrexate Isn’t Enough
If methotrexate alone doesn’t bring your disease under adequate control within three to six months, the next step is usually adding a biologic DMARD. These are lab-engineered proteins that target specific parts of the immune system driving your inflammation, rather than suppressing immune function broadly.
The most commonly used biologics are TNF inhibitors. TNF-alpha is a signaling protein your immune system uses to trigger inflammation. In rheumatoid arthritis, your body produces too much of it. TNF inhibitors block this protein from attaching to cells and setting off the inflammatory chain reaction. Five TNF inhibitors are FDA-approved, and they’re given either as self-administered injections at home or as infusions at a clinic.
If a TNF inhibitor doesn’t work well for you, or if you experience side effects, other biologic options target different parts of the immune system. One approach blocks a signaling protein called IL-6 that drives inflammation through a separate pathway. Another approach uses a therapy that depletes certain immune cells (B cells) that contribute to joint damage. If one biologic fails, your rheumatologist can switch you to a different one, either from the same class or a completely different class. There’s no single correct sequence after the first-line treatment, and the choice depends on your specific situation.
JAK Inhibitors: An Oral Alternative
JAK inhibitors are a newer category of targeted therapy that comes in pill form rather than injections. They work inside your cells by blocking enzymes called Janus kinases, which relay inflammatory signals from the cell surface to the nucleus. By interrupting this relay, they reduce the production of inflammatory molecules.
These medications are effective, but they carry specific safety considerations that placed them later in the treatment sequence. In 2021, the FDA added warnings after a large safety study found modestly higher rates of serious cardiovascular events (heart attacks and strokes), blood clots, and certain cancers compared to TNF inhibitors. Current guidelines recommend JAK inhibitors only after at least one TNF inhibitor has failed or can’t be used. For people over 65, those with cardiovascular risk factors, or current and former smokers, the risk-benefit conversation with a rheumatologist is especially important.
The Treat-to-Target Approach
Modern rheumatoid arthritis management follows a strategy called “treat to target,” where the goal is a specific, measurable level of disease control, ideally remission. This means regular check-ins (often every one to three months in early treatment) where your rheumatologist assesses your joint tenderness, swelling, and blood markers of inflammation using a standardized scoring system. If you haven’t hit the target, treatment is adjusted.
This approach produces impressive results. In a real-world study tracking patients on biologics with this strategy over five years, 89% achieved remission and another 5% reached low disease activity. Starting treatment early, before significant joint damage accumulates, is one of the strongest predictors of a good outcome. The first two years after diagnosis are considered a critical window.
Joint Protection and Occupational Therapy
Medication controls the disease process, but protecting your joints day to day is equally important for maintaining function. Occupational therapy teaches practical techniques that reduce strain on inflamed joints during routine activities.
The core principles are straightforward but make a real difference over time:
- Spread the load. Distribute weight across multiple joints instead of concentrating it. Carry items with two hands instead of one. Use your palms rather than gripping with your fingers.
- Use your largest, strongest joints. Push a door open with your forearm instead of your fingers. Carry a bag on your shoulder rather than in your hand.
- Avoid sustained gripping. Don’t hold the same position for long periods. Built-up handles on kitchen tools, pens, and utensils reduce the grip force needed.
- Reduce effort with assistive devices. Jar openers, electric can openers, lever-style door handles, and lightweight cookware all lower the physical demands on your hands and wrists.
- Pace your activities. Alternate heavy and light tasks. Build in rest breaks before fatigue sets in rather than pushing through and paying for it later.
Hand exercises prescribed by a therapist can also help maintain grip strength and range of motion. Splints or orthoses worn during flares or at night support joints in proper alignment and reduce pain.
Exercise and Physical Activity
Regular exercise improves joint flexibility, muscle strength, cardiovascular health, and fatigue levels in people with rheumatoid arthritis. Low-impact activities like swimming, cycling, walking, and yoga are particularly well suited because they build fitness without excessive joint stress. Strength training is also beneficial and helps stabilize joints by building the muscles around them.
During flares, you may need to scale back intensity, but complete rest for extended periods tends to increase stiffness and weaken muscles. Gentle range-of-motion exercises can usually continue even when joints are more active.
Diet: What the Evidence Actually Shows
The connection between diet and rheumatoid arthritis symptoms is real but more modest than many popular sources suggest. A Mediterranean-style diet, rich in fish, olive oil, vegetables, and whole grains, has shown some benefit, but a large Swedish study found it appeared to help mainly in patients who tested positive for specific RA-related antibodies. In antibody-negative patients, the effect wasn’t clear.
A rigorous clinical trial of an anti-inflammatory diet found no significant difference in disease activity scores compared to a control diet. Some individual findings are interesting. Keeping intake of arachidonic acid (found in red meat and egg yolks) very low appeared to reduce clinical signs of inflammation and boosted the benefit of fish oil supplementation. But overall, the evidence isn’t strong enough to say any specific diet reliably reduces RA disease activity on its own. A nutrient-dense diet supports general health and may offer a small additional benefit on top of medication, but it’s not a substitute for DMARD therapy.
How Treatment Progresses Over Time
The typical treatment journey starts with methotrexate, often alongside a short steroid course. If that combination brings you to remission or low disease activity within three to six months, you stay the course. If not, a biologic is added, usually a TNF inhibitor first. If the first biologic doesn’t work, you switch to another biologic or, with appropriate risk discussion, a JAK inhibitor.
Once you’ve been in sustained remission for a meaningful period, your rheumatologist may cautiously reduce medications, typically tapering biologics first while continuing methotrexate. Complete drug-free remission is possible for some people, but most need ongoing treatment at some level to keep the disease from returning. The encouraging reality is that with today’s medications and the treat-to-target approach, the majority of people with rheumatoid arthritis can achieve well-controlled disease and maintain their quality of life.